Brands like Kourtney Kardashian’s Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, ...

Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filing in the gaps.

Image credit Weight loss is an incredible journey; if you’ve been through it, you know how frustrating and overwhelmin ...

Hims & Hers shares tanked after regulators signaled new limits on the production of versions of weight-loss drugs.

GLP-1 supplement makers claim that their products work similarly to weight loss injections like Ozempic. Here's what experts ...

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

Research shows patients taking weight-loss drugs like Ozempic and Wegovy are more likely to have food left in the stomach or ...

Agents like semaglutide show promise for treatment of substance use disorders. Inaccessibility of GLP-1 agonists due to high ...

"There is a clear association between the use of GLPs and increased risks of food retention during upper endoscopy," Mathur ...

Hims & Hers' (HIMS) stock drop marks the latest overhang on a company that has more than doubled in value over the past 12 ...

Digbi Health, a leader in Precision Biology and personalized healthcare, has been invited to present a landmark study at the ...